Conserved Aberrant Developmental Trajectories of Human and Mouse SBMA Motor Neurons
Authors:
- Helen DevineHDHelen Devine
- Martha J RobertsMRMartha J Roberts
- Oliver J ZiffOZOliver J Ziff
- Michael G HannaMHMichael G Hanna
- Linda GreensmithLGLinda Greensmith
- Rickie PataniRPRickie Patani
- Bilal MalikBMBilal Malik
Preprint
Abstract
Spinal bulbar muscular atrophy (SBMA) is a neuromuscular disease caused by a polyglutamine repeat expansion in the androgen receptor gene (AR). Lower motor neuron loss is a key feature of the disease, yet it remains poorly understood why these cells are affected. The transcriptional mechanisms underlying SBMA pathogenesis and how these evolve across developmental and disease stages remains incompletely defined. To elucidate the molecular mechanisms underlying motor neuron loss in SBMA, we first performed transcriptomic profiling of both induced pluripotent stem cell derived motor neurons (iPSC-MNs) generated from SBMA patients and laser-captured micro dissected motor neurons (LCM-MNs) from symptomatic AR100 SBMA mice. We compared differential gene expression between the two models to identify shared transcriptional programs. To address the temporal progression of molecular changes we conducted profiling at key stages of motor neurogenesis in the developing iPSC-MNs and at pre-symptomatic and end-stage disease in AR100 SBMA mice to elucidate the emergence of the transcriptional phenotype and the trajectory of the gene expression changes. We found significant transcriptional convergence between these two species. Notably, shared dysregulation was observed in pathways related to the spliceosome, the cell cycle and mitochondrial function. These transcriptional alterations emerged early in motor neurogenesis suggesting a developmental component to SBMA. Further in AR100 LCM-MNs we also observed disruption of mitochondrial and DNA damage repair pathways from pre-symptomatic to end stage disease. This study identifies conserved pathogenic mechanisms across two SBMA model systems and provides crucial insights into the molecular basis and temporal dynamics of SBMA progression which may help identify potential therapeutic targets for SBMA. Abstract Figure:Keywords
Funding Information
- MRC
This publication has 39 references indexed in Scilit:
- PolyQ length-dependent metabolic alterations and DNA damage drive human astrocyte dysfunction in Huntington’s diseaseProgress in Neurobiology, 2023
- Gene Set Knowledge Discovery with EnrichrCurrent Protocols, 2021
- Molecular Mechanisms and Therapeutics for SBMA/Kennedy's DiseaseNeurotherapeutics, 2019
- Phenotypic and molecular features underlying neurodegeneration of motor neurons derived from spinal and bulbar muscular atrophy patientsNeurobiology of Disease, 2019
- Splicing and neurodegeneration: Insights and mechanismsWIREs RNA, 2019
- X-Linked Spinal and Bulbar Muscular Atrophy: From Clinical Genetic Features and Molecular Pathology to Mechanisms Underlying Disease Toxicity2018
- Mitochondrial hyperpolarization in iPSC-derived neurons from patients of FTDP-17 with 10+16 MAPT mutation leads to oxidative stress and neurodegenerationRedox Biology, 2017
- Progressive Motor Neuron Pathology and the Role of Astrocytes in a Human Stem Cell Model of VCP-Related ALSCell Reports, 2017
- Stem cell-derived motor neurons from spinal and bulbar muscular atrophy patientsNeurobiology of Disease, 2014
- The Hallmarks of AgingCell, 2013